Angiotensin II for the Treatment of Vasodilatory Shock

作者: Ashish Khanna , Shane W English , Xueyuan S Wang , Kealy Ham , James Tumlin

DOI: 10.1056/NEJMOA1704154

关键词:

摘要: BackgroundVasodilatory shock that does not respond to high-dose vasopressors is associated with high mortality. We investigated the effectiveness of angiotensin II for treatment patients this condition. MethodsWe randomly assigned vasodilatory who were receiving more than 0.2 μg norepinephrine per kilogram body weight minute or equivalent dose another vasopressor receive infusions either placebo. The primary end point was a response respect mean arterial pressure at hour 3 after start infusion, defined as an increase from baseline least 10 mm Hg 75 Hg, without in background vasopressors. ResultsA total 344 one two regimens; 321 received study intervention (163 II, and 158 placebo) included analysis. reached by angiote...

参考文章(23)
J. -L. Vincent, R. Moreno, J. Takala, S. Willatts, A. De Mendonça, H. Bruining, C. K. Reinhart, P. M. Suter, L. G. Thijs, The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Medicine. ,vol. 22, pp. 707- 710 ,(1996) , 10.1007/BF01709751
Stanley E. Bradley, Barbara Parker, THE HEMODYNAMIC EFFECTS OF ANGIOTONIN IN NORMAL MAN 1 Journal of Clinical Investigation. ,vol. 20, pp. 715- 719 ,(1941) , 10.1172/JCI101265
Samuel M. Brown, Michael J. Lanspa, Jason P. Jones, Kathryn G. Kuttler, Yao Li, Rick Carlson, Russell R. Miller, Eliotte L. Hirshberg, Colin K. Grissom, Alan H. Morris, Survival After Shock Requiring High-Dose Vasopressor Therapy Chest. ,vol. 143, pp. 664- 671 ,(2013) , 10.1378/CHEST.12-1106
Allan D. Struthers, Sudha Pai, Peter H. Seidelin, Wendy J.R. Coutie, James J. Morton, Evidence in humans for a postsynaptic interaction between noradrenaline and angiotensin II with regard to systolic but not diastolic blood pressure. Journal of Hypertension. ,vol. 5, pp. 671- 676 ,(1987) , 10.1097/00004872-198712000-00006
Lakhmir S Chawla, Laurence Busse, Ermira Brasha-Mitchell, Danielle Davison, Jacqueline Honiq, Ziyad Alotaibi, Michael G Seneff, Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study Critical Care. ,vol. 18, pp. 534- 534 ,(2014) , 10.1186/S13054-014-0534-9
VAUGHAN L. THOMAS, MICHAEL S. NIELSEN, Administration of angiotensin II in refractory septic shock. Critical Care Medicine. ,vol. 19, pp. 1084- 1085 ,(1991) , 10.1097/00003246-199108000-00020
JOHN R. DERRICK, JAMES R. ANDERSON, BOBBY J. ROLAND, Adjunctive use of a biologic pressor agent, angiotensin, in management of shock. Circulation. ,vol. 25, pp. 263- 267 ,(1962) , 10.1161/01.CIR.25.1.263
Nidia Basso, Norberto A. Terragno, History about the discovery of the renin-angiotensin system. Hypertension. ,vol. 38, pp. 1246- 1249 ,(2001) , 10.1161/HY1201.101214
G.M. Wray, J.H. Coakley, Severe septic shock unresponsive to noradrenaline The Lancet. ,vol. 346, pp. 1604- ,(1995) , 10.1016/S0140-6736(95)91933-3